SpringWorks Therapeutics ...

NASDAQ: SWTX · Real-Time Price · USD
46.99
0.00 (0.00%)
At close: Jun 30, 2025, 3:59 PM

SpringWorks Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
191.59M 5.45M 6.15M n/a
Cost of Revenue
12.55M 422K 1.9M 490K
Gross Profit
179.04M 5.03M 4.25M -490K
Operating Income
-278.13M -343.01M -280.67M -173.47M
Interest Income
26M 22.95M 6.15M 698K
Pretax Income
-258.13M -325.1M -277.42M -173.91M
Net Income
-258.13M -325.1M -274.16M -173.21M
Selling & General & Admin
256.65M 197.55M 134.55M 71.79M
Research & Development
200.52M 150.49M 146.12M 101.68M
Other Expenses
n/a n/a -138K -152K
Operating Expenses
457.17M 348.04M 280.67M 173.47M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
469.72M 348.46M 280.67M 173.47M
Income Tax Expense
n/a n/a -3.26M -698K
Shares Outstanding (Basic)
74.13M 63.12M 53.29M 48.5M
Shares Outstanding (Diluted)
74.13M 63.12M 53.29M 48.5M
EPS (Basic)
-3.48 -5.15 -5.14 -3.57
EPS (Diluted)
-3.48 -5.15 -5.14 -3.57
EBITDA
-278.13M -341.35M -280.67M -172.98M
EBIT
-278.13M -343.01M -277.42M -173.47M
Depreciation & Amortization
n/a 1.67M 1.9M 490K